Carmela Zuniga
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Carmela Zuniga has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
Alexandra Wollum
Ibis Reproductive Health, Oakland, CA, United States
4 shared publications- Alexandra Wollum
Ibis Reproductive Health, Oakland, CA, United States
4 shared publications - Terri-Ann Thompson
Ibis Reproductive Health
4 shared publications - Kate Grindlay
Caila Brander and Kate Grindlay are with Ibis Reproductive Health, Cambridge, MA. Caitlin Russell is with the School of Nursing, University of Pennsylvania, Philadelphia. Elisa Cardnell is with Service Women's Action Network, Washington, DC. Caitlin Gerdts is with Ibis Reproductive Health, Oakland, CA
3 shared publications Kelly Blanchard
Ibis Reproductive Health, Cambridge, MA, United States
3 shared publicationsTerri-Ann Thompson
Ibis Reproductive Health, Cambridge, Massachusetts, United States of America
3 shared publications
Latest Publications
- Open Access
- 21 November 2025
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 5  (11) , e0005432
Changes in early abortion access among out-of-state abortion patients in Illinois, following public insurance coverage through state Medicaid: A brief research report
In 2018, Illinois implemented House Bill 40 (HB40) which required Medicaid (means-tested public insurance) coverage of abortion care for Illinois residents. Medicaid coverage of abortion increases financial accessibility, which oftentimes leads to earlier access to care for covered patients. The ability of residents to use Medicaid may have increased the availability of financial assistance for non-residents. However, whether Medicaid coverage is associated with any changes in abortion access among out-of-state patients – who cannot use Medicaid for abortion coverage – is unknown. To explore if Medicaid coverage of abortion is associated with changes in abortion access for out-of-state patients, we analyzed de-identified records of abortion visits among non-Illinois residents presenting for abortion care across 12 Illinois health centers. We used logistic regression to assess if presenting early for an abortion (≤11 weeks gestation) was associated with implementation of HB40 (2017 vs 2018–2019). Although out-of-state residents were more likely to present early if they received abortion care in the post-HB40 period than pre-HB40 (81% at ≤11 weeks in 2018–2019 vs 78% in 2017), multivariable regression shows that HB40 was not associated with early abortion access when controlling for other patient characteristics. Out-of-state patients had higher odds of presenting ≤11 weeks of gestation during the study period if they were a resident of a state bordering Illinois (OR 1.89, 95% CI 1.55-2.30, p < 0.001) or were over the age of 24 (OR 1.50, 95% CI 1.35-1.66; p < 0.001). Given the significant rise in out-of-state patients after the Dobbs decision, future research should explore how large increases in patient volume over time have impacted abortion care in Illinois and other states, and assess how federal and state-level legal or policy changes influence abortion access for out-of-state patients.
- 21 November 2025
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 5  (11) , e0005432
Open AccessChanges in early abortion access among out-of-state abortion patients in Illinois, following public insurance coverage through state Medicaid: A brief research report
In 2018, Illinois implemented House Bill 40 (HB40) which required Medicaid (means-tested public insurance) coverage of abortion care for Illinois residents. Medicaid coverage of abortion increases financial accessibility, which oftentimes leads to earlier access to care for covered patients. The ability of residents to use Medicaid may have increased the availability of financial assistance for non-residents. However, whether Medicaid coverage is associated with any changes in abortion access among out-of-state patients – who cannot use Medicaid for abortion coverage – is unknown. To explore if Medicaid coverage of abortion is associated with changes in abortion access for out-of-state patients, we analyzed de-identified records of abortion visits among non-Illinois residents presenting for abortion care across 12 Illinois health centers. We used logistic regression to assess if presenting early for an abortion (≤11 weeks gestation) was associated with implementation of HB40 (2017 vs 2018–2019). Although out-of-state residents were more likely to present early if they received abortion care in the post-HB40 period than pre-HB40 (81% at ≤11 weeks in 2018–2019 vs 78% in 2017), multivariable regression shows that HB40 was not associated with early abortion access when controlling for other patient characteristics. Out-of-state patients had higher odds of presenting ≤11 weeks of gestation during the study period if they were a resident of a state bordering Illinois (OR 1.89, 95% CI 1.55-2.30, p < 0.001) or were over the age of 24 (OR 1.50, 95% CI 1.35-1.66; p < 0.001). Given the significant rise in out-of-state patients after the Dobbs decision, future research should explore how large increases in patient volume over time have impacted abortion care in Illinois and other states, and assess how federal and state-level legal or policy changes influence abortion access for out-of-state patients.
- Open Access
- 27 June 2025
- Published by Taylor & Francis in Sexual and Reproductive Health Matters
- Vol. 33  (1) , 1-29
Preferred use of contraceptive methods and reasons for non-use: a cross-sectional survey of a sample of Black, Indigenous, and people of colour in the United States
Use of preferred contraceptive methods is a measure of reproductive autonomy, yet barriers persist across the United States in accessing preferred methods of contraception, with disparities in access among communities of color. Using data from a 2021-2022 cross-sectional survey of 727 people aged 13-50 and living in the United States who identified as Asian American, Native Hawaiian, or Pacific Islander (29%); Black or African American (34%), Indigenous (13%), and Latina/Latinx (31%), we examined those who were not using their preferred contraceptive method(s), including the preferred method type and the reasons for not using this method(s). We ran an adjusted logistic regression to test the association between the quality of the last health care interaction related to contraception and the use of a non-preferred method. Thirty-seven percent of respondents preferred a contraceptive method they were not currently using. Among current contraceptive users, long-acting methods were preferred most often, while non-current contraceptive users desired long-acting and short-acting hormonal methods equally. Respondents most often cited concerns about side effects/health risks (65%) and financial/logistical reasons (42%) as the top reasons for not using their preferred method(s). Those who reported receiving higher quality care in a recent contraceptive visit were more likely to be using the method they wanted to be using. Use of a preferred contraceptive method may increase when receiving high-quality counselling and care. Strategies to improve access to preferred methods should address side effects and health concerns, as well as financial and logistical barriers among Black, Indigenous, and people of color.
- 27 June 2025
- Published by Taylor & Francis in Sexual and Reproductive Health Matters
- Vol. 33  (1) , 1-29
Open AccessPreferred use of contraceptive methods and reasons for non-use: a cross-sectional survey of a sample of Black, Indigenous, and people of colour in the United States
Use of preferred contraceptive methods is a measure of reproductive autonomy, yet barriers persist across the United States in accessing preferred methods of contraception, with disparities in access among communities of color. Using data from a 2021-2022 cross-sectional survey of 727 people aged 13-50 and living in the United States who identified as Asian American, Native Hawaiian, or Pacific Islander (29%); Black or African American (34%), Indigenous (13%), and Latina/Latinx (31%), we examined those who were not using their preferred contraceptive method(s), including the preferred method type and the reasons for not using this method(s). We ran an adjusted logistic regression to test the association between the quality of the last health care interaction related to contraception and the use of a non-preferred method. Thirty-seven percent of respondents preferred a contraceptive method they were not currently using. Among current contraceptive users, long-acting methods were preferred most often, while non-current contraceptive users desired long-acting and short-acting hormonal methods equally. Respondents most often cited concerns about side effects/health risks (65%) and financial/logistical reasons (42%) as the top reasons for not using their preferred method(s). Those who reported receiving higher quality care in a recent contraceptive visit were more likely to be using the method they wanted to be using. Use of a preferred contraceptive method may increase when receiving high-quality counselling and care. Strategies to improve access to preferred methods should address side effects and health concerns, as well as financial and logistical barriers among Black, Indigenous, and people of color.
- Open Access
- 1 January 2025
- Published by BMJ in BMJ Public Health
- Vol. 3  (1) , e001966
Changes in abortion access after implementation of Medicaid coverage in Illinois: a retrospective analysis
Introduction: In 2018, Illinois implemented House Bill 40 (HB-40), allowing state funds to provide Medicaid coverage for abortion. This study aimed to quantitatively measure changes in access among Illinois residents after the law’s implementation, with a focus on changes experienced by Medicaid versus non-Medicaid patients. Methods: We conducted a retrospective analysis using 67 462 abortion visits across 18 health centres comparing service delivery patterns 1 year before and 3 years after HB-40 implementation. We used a t-test and difference-in-differences regression to assess the policy’s effect on mean gestational age at the time of abortion among Medicaid patients and non-Medicaid patients. We used χ2 tests to capture differences in insurance type used for payment, as well as differences between Medicaid and non-Medicaid patients in presenting at ≤11 weeks gestation, abortion method provided and time between scheduling and getting an abortion. Results: From 2017 to 2020, the overall volume of abortions increased by 27% and the share of abortions paid for with Medicaid increased from 15% to 49%. Compared with non-Medicaid patients, Medicaid patients experienced a significant decrease in average gestational age at the time of abortion post-HB-40 (incidence rate ratio (IRR)=0.93, 95% CI 0.91 to 0.95, p<0.001). The proportion of Medicaid patients ≤11 weeks gestation increased post-HB-40 (76% to 83%; p<0.001) but did not change among non-Medicaid patients (89% to 90%; p=0.62). By 2020, the 13%-point gap that existed between the two groups in 2017 (76% and 89%) was reduced to 4 (86% and 90%). The proportion of medication abortions increased substantially for Medicaid patients post-HB-40 (27% to 46%; p<0.001) and increased slightly for non-Medicaid patients (51% to 53%; p=0.001), resulting in decreased gaps in medication abortions received between the two groups. Conclusion: Medicaid coverage of abortion reduced insurance-related disparities for Medicaid patients, as shown by decreased gaps in average gestational age among Medicaid and non-Medicaid patients. It was also associated with increased medication abortions among Medicaid patients.
- 1 January 2025
- Published by BMJ in BMJ Public Health
- Vol. 3  (1) , e001966
Open AccessChanges in abortion access after implementation of Medicaid coverage in Illinois: a retrospective analysis
Introduction: In 2018, Illinois implemented House Bill 40 (HB-40), allowing state funds to provide Medicaid coverage for abortion. This study aimed to quantitatively measure changes in access among Illinois residents after the law’s implementation, with a focus on changes experienced by Medicaid versus non-Medicaid patients. Methods: We conducted a retrospective analysis using 67 462 abortion visits across 18 health centres comparing service delivery patterns 1 year before and 3 years after HB-40 implementation. We used a t-test and difference-in-differences regression to assess the policy’s effect on mean gestational age at the time of abortion among Medicaid patients and non-Medicaid patients. We used χ2 tests to capture differences in insurance type used for payment, as well as differences between Medicaid and non-Medicaid patients in presenting at ≤11 weeks gestation, abortion method provided and time between scheduling and getting an abortion. Results: From 2017 to 2020, the overall volume of abortions increased by 27% and the share of abortions paid for with Medicaid increased from 15% to 49%. Compared with non-Medicaid patients, Medicaid patients experienced a significant decrease in average gestational age at the time of abortion post-HB-40 (incidence rate ratio (IRR)=0.93, 95% CI 0.91 to 0.95, p<0.001). The proportion of Medicaid patients ≤11 weeks gestation increased post-HB-40 (76% to 83%; p<0.001) but did not change among non-Medicaid patients (89% to 90%; p=0.62). By 2020, the 13%-point gap that existed between the two groups in 2017 (76% and 89%) was reduced to 4 (86% and 90%). The proportion of medication abortions increased substantially for Medicaid patients post-HB-40 (27% to 46%; p<0.001) and increased slightly for non-Medicaid patients (51% to 53%; p=0.001), resulting in decreased gaps in medication abortions received between the two groups. Conclusion: Medicaid coverage of abortion reduced insurance-related disparities for Medicaid patients, as shown by decreased gaps in average gestational age among Medicaid and non-Medicaid patients. It was also associated with increased medication abortions among Medicaid patients.
- Open Access
- 18 April 2023
- Published by Frontiers Media SA in Frontiers in Global Women's Health
- Vol. 4
Recruiting foreign-born individuals who have sought an abortion in the United States: Lessons from a feasibility study
Although studies have documented challenges people encounter when attempting to access abortion care in the United States, there is little research on the perspectives and experiences of foreign-born individuals, who may encounter unique barriers to accessing care. Since lack of data may be due to difficulty recruiting this population, we explored the feasibility of using social media to recruit foreign-born individuals who have sought an abortion into interviews to share their abortion experiences. Our target population was limited to English and Spanish-speakers due to budget constraints. As this recruitment method was unsuccessful, we attempted to recruit our target population through the crowdsourcing website, Amazon Mechanical Turk (mTurk) to take a one-time survey on their abortion experience. Both online recruitment methods yielded a significant number of fraudulent responses. Although we aimed to collaborate with organizations that work closely with immigrant populations, they were unavailable to assist with recruitment efforts at the time of the study. Future abortion research utilizing online methods to recruit foreign-born populations should consider incorporating information on their target populations' use of online platforms as well as cultural views on abortion in order to develop effective recruitment strategies.
- 18 April 2023
- Published by Frontiers Media SA in Frontiers in Global Women's Health
- Vol. 4
Open AccessRecruiting foreign-born individuals who have sought an abortion in the United States: Lessons from a feasibility study
Although studies have documented challenges people encounter when attempting to access abortion care in the United States, there is little research on the perspectives and experiences of foreign-born individuals, who may encounter unique barriers to accessing care. Since lack of data may be due to difficulty recruiting this population, we explored the feasibility of using social media to recruit foreign-born individuals who have sought an abortion into interviews to share their abortion experiences. Our target population was limited to English and Spanish-speakers due to budget constraints. As this recruitment method was unsuccessful, we attempted to recruit our target population through the crowdsourcing website, Amazon Mechanical Turk (mTurk) to take a one-time survey on their abortion experience. Both online recruitment methods yielded a significant number of fraudulent responses. Although we aimed to collaborate with organizations that work closely with immigrant populations, they were unavailable to assist with recruitment efforts at the time of the study. Future abortion research utilizing online methods to recruit foreign-born populations should consider incorporating information on their target populations' use of online platforms as well as cultural views on abortion in order to develop effective recruitment strategies.
- Open Access
- 16 December 2022
- Published by Elsevier in Contraception
- Vol. 119, 109925
Effectiveness and efficacy rates of progestin-only pills: A comprehensive literature review
- 16 December 2022
- Published by Elsevier in Contraception
- Vol. 119, 109925
Open AccessEffectiveness and efficacy rates of progestin-only pills: A comprehensive literature review
- 21 October 2022
- Published by BMJ in BMJ Sexual & Reproductive Health
- Vol. 49  (1) , 27-34
Experiences using a progestin-only pill in an over-the-counter environment in the United States: a cross-sectional survey
Background Efforts are underway to make a progestin-only pill (POP) over the counter (OTC) in the United States (US); however, little is known about POP user experiences, which could impact uptake and continuation. Methods From January 2020–September 2021, we conducted a cross-sectional online survey with individuals who used OTC POPs in a US trial. We calculated descriptive statistics and Pearson chi-square and Fisher’s exact tests to assess menstrual bleeding acceptability, how OTC POP experiences compared with prior contraceptive methods, and preferred ways to get answers to questions during OTC POP use. Results Among 550 adult and 115 adolescent participants, 80% (n=531) felt their menstrual bleeding was acceptable. Participants reported a range of menstrual bleeding experiences compared with prior long-acting or hormonal methods used; 58% (n=84) said the POP bleeding was similar or better and 36% (n=53) said it was worse. Among participants who used contraception in the month prior to the trial, 77% (n=201) said their overall OTC POP experience was similar or better. Top benefits compared with prior methods included less worry about pregnancy, ease of access, fewer side effects, and greater decision-making power. Adults preferred to get answers about OTC POPs via webpage or app, whereas teens preferred asking pharmacists or other healthcare providers. Conclusions Overall, OTC POP users in a trial setting found the menstrual bleeding acceptable and the method similar to or better than previous methods. POP labelling should provide clear messaging about bleeding changes users may experience.
- 21 October 2022
- Published by BMJ in BMJ Sexual & Reproductive Health
- Vol. 49  (1) , 27-34
Experiences using a progestin-only pill in an over-the-counter environment in the United States: a cross-sectional survey
Background Efforts are underway to make a progestin-only pill (POP) over the counter (OTC) in the United States (US); however, little is known about POP user experiences, which could impact uptake and continuation. Methods From January 2020–September 2021, we conducted a cross-sectional online survey with individuals who used OTC POPs in a US trial. We calculated descriptive statistics and Pearson chi-square and Fisher’s exact tests to assess menstrual bleeding acceptability, how OTC POP experiences compared with prior contraceptive methods, and preferred ways to get answers to questions during OTC POP use. Results Among 550 adult and 115 adolescent participants, 80% (n=531) felt their menstrual bleeding was acceptable. Participants reported a range of menstrual bleeding experiences compared with prior long-acting or hormonal methods used; 58% (n=84) said the POP bleeding was similar or better and 36% (n=53) said it was worse. Among participants who used contraception in the month prior to the trial, 77% (n=201) said their overall OTC POP experience was similar or better. Top benefits compared with prior methods included less worry about pregnancy, ease of access, fewer side effects, and greater decision-making power. Adults preferred to get answers about OTC POPs via webpage or app, whereas teens preferred asking pharmacists or other healthcare providers. Conclusions Overall, OTC POP users in a trial setting found the menstrual bleeding acceptable and the method similar to or better than previous methods. POP labelling should provide clear messaging about bleeding changes users may experience.
- 1 June 2021
- Published by Elsevier in Contraception
- Vol. 103  (6) , 414-419
Lessons learned: Illinois providers’ perspectives on implementation of Medicaid coverage for abortion
- 1 June 2021
- Published by Elsevier in Contraception
- Vol. 103  (6) , 414-419
Lessons learned: Illinois providers’ perspectives on implementation of Medicaid coverage for abortion
- Open Access
- 24 February 2021
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 5  (2) , e22854
Comparison of Facebook, Google Ads, and Reddit for the Recruitment of People Who Considered but Did Not Obtain Abortion Care in the United States: Cross-sectional Survey
Background: In the United States, abortion access is restricted by numerous logistical, financial, social, and policy barriers. Most studies on abortion-seeking experiences in the United States have recruited participants from abortion clinics. However, clinic-based recruitment strategies fail to capture the experiences of people who consider an abortion but do not make it to an abortion clinic. Research indicates that many people search for abortion information on the web; however, web-based recruitment remains underutilized in abortion research. Objective: This study aims to establish the feasibility of using Facebook, Google Ads, and Reddit as recruitment platforms for a study on abortion-seeking experiences in the United States. Methods: From August to September 2018, we posted recruitment advertisements for a survey about abortion-seeking experiences through Facebook, Google Ads, and Reddit. Eligible participants were US residents aged 15-49 years who had been pregnant in the past 5 years and had considered abortion for a pregnancy in this period but did not abort. For each platform, we recorded staff time to develop advertisements and manage recruitment, as well as costs related to advertisement buys and social marketing firm support. We summarized the number of views and clicks for each advertisement where possible, and we calculated metrics related to cost per recruited participant and recruitment rate by week for each platform. We assessed differences across platforms using the chi-square and Kruskal-Wallis tests. Results: Overall, study advertisements received 77,464 views in the 1-month period (from Facebook and Google; information not available for Reddit) and 2808 study page views. After clicking on the advertisements, there were 1254 initiations of the eligibility screening survey, which resulted in 98 eligible survey participants (75 recruited from Facebook, 14 from Google Ads, and 9 from Reddit). The cost for each eligible participant in each platform was US $49.48 for Facebook, US $265.93 for Google Ads, and US $182.78 for Reddit. A total of 84% (66/79) of those who screened eligible from Facebook completed the short survey compared with 73% (8/11) of those who screened eligible from Reddit and 13% (7/53) of those who screened eligible from Google Ads. Conclusions: These results suggest that Facebook advertisements may be the most time- and cost-effective strategy to recruit people who considered but did not obtain an abortion in the United States. Adapting and implementing Facebook-based recruitment strategies for research on abortion access could facilitate a more complete understanding of the barriers to abortion care in the United States.
- 24 February 2021
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 5  (2) , e22854
Open AccessComparison of Facebook, Google Ads, and Reddit for the Recruitment of People Who Considered but Did Not Obtain Abortion Care in the United States: Cross-sectional Survey
Background: In the United States, abortion access is restricted by numerous logistical, financial, social, and policy barriers. Most studies on abortion-seeking experiences in the United States have recruited participants from abortion clinics. However, clinic-based recruitment strategies fail to capture the experiences of people who consider an abortion but do not make it to an abortion clinic. Research indicates that many people search for abortion information on the web; however, web-based recruitment remains underutilized in abortion research. Objective: This study aims to establish the feasibility of using Facebook, Google Ads, and Reddit as recruitment platforms for a study on abortion-seeking experiences in the United States. Methods: From August to September 2018, we posted recruitment advertisements for a survey about abortion-seeking experiences through Facebook, Google Ads, and Reddit. Eligible participants were US residents aged 15-49 years who had been pregnant in the past 5 years and had considered abortion for a pregnancy in this period but did not abort. For each platform, we recorded staff time to develop advertisements and manage recruitment, as well as costs related to advertisement buys and social marketing firm support. We summarized the number of views and clicks for each advertisement where possible, and we calculated metrics related to cost per recruited participant and recruitment rate by week for each platform. We assessed differences across platforms using the chi-square and Kruskal-Wallis tests. Results: Overall, study advertisements received 77,464 views in the 1-month period (from Facebook and Google; information not available for Reddit) and 2808 study page views. After clicking on the advertisements, there were 1254 initiations of the eligibility screening survey, which resulted in 98 eligible survey participants (75 recruited from Facebook, 14 from Google Ads, and 9 from Reddit). The cost for each eligible participant in each platform was US $49.48 for Facebook, US $265.93 for Google Ads, and US $182.78 for Reddit. A total of 84% (66/79) of those who screened eligible from Facebook completed the short survey compared with 73% (8/11) of those who screened eligible from Reddit and 13% (7/53) of those who screened eligible from Google Ads. Conclusions: These results suggest that Facebook advertisements may be the most time- and cost-effective strategy to recruit people who considered but did not obtain an abortion in the United States. Adapting and implementing Facebook-based recruitment strategies for research on abortion access could facilitate a more complete understanding of the barriers to abortion care in the United States.
- 30 November 2020
- Published by Taylor & Francis in Global Public Health
- Vol. 17  (1) , 83-99
The impacts of contraceptive stock-outs on users, providers, and facilities: A systematic literature review
Contraceptive stock-outs are a world-wide problem, yet published research on the impacts of contraceptive stock-outs have not been comprehensively reviewed and synthesised. This systematic review highlights findings about the impacts of contraceptive stock-outs on users, providers, and facilities and identifies topics that should be explored to ensure everyone can access their preferred method of contraception. We systematically searched PubMed, Embase, Web of Science, Popline, and JSTOR for studies addressing the impacts of contraceptive stock-outs. Of 435 studies, 25 publications addressed the impacts of contraceptive stock-outs. Only two articles focused solely on contraceptive stock-outs; the remaining studies examined stock-outs alongside other factors that may influence contraceptive service provision. Studies discussed how stock-outs limited individuals’ ability to use their preferred contraceptive method, influenced where contraceptive methods were obtained and how much they cost, and limited providers’ and facilities’ abilities to provide contraceptive care. Comparing the impacts of contraceptive stock-outs across studies was challenging, as reliability of stock was sometimes not distinguished from overall method availability, and studies used variable methods to measure stock-outs. Evidence presented in this review can inform efforts to ensure that preferred contraceptive methods are consistently available and accessible to all.
- 30 November 2020
- Published by Taylor & Francis in Global Public Health
- Vol. 17  (1) , 83-99
The impacts of contraceptive stock-outs on users, providers, and facilities: A systematic literature review
Contraceptive stock-outs are a world-wide problem, yet published research on the impacts of contraceptive stock-outs have not been comprehensively reviewed and synthesised. This systematic review highlights findings about the impacts of contraceptive stock-outs on users, providers, and facilities and identifies topics that should be explored to ensure everyone can access their preferred method of contraception. We systematically searched PubMed, Embase, Web of Science, Popline, and JSTOR for studies addressing the impacts of contraceptive stock-outs. Of 435 studies, 25 publications addressed the impacts of contraceptive stock-outs. Only two articles focused solely on contraceptive stock-outs; the remaining studies examined stock-outs alongside other factors that may influence contraceptive service provision. Studies discussed how stock-outs limited individuals’ ability to use their preferred contraceptive method, influenced where contraceptive methods were obtained and how much they cost, and limited providers’ and facilities’ abilities to provide contraceptive care. Comparing the impacts of contraceptive stock-outs across studies was challenging, as reliability of stock was sometimes not distinguished from overall method availability, and studies used variable methods to measure stock-outs. Evidence presented in this review can inform efforts to ensure that preferred contraceptive methods are consistently available and accessible to all.
- 1 November 2020
- Published by Elsevier in Women's Health Issues
- Vol. 30  (6) , 416-425
Abortion as a Catastrophic Health Expenditure in the United States
- 1 November 2020
- Published by Elsevier in Women's Health Issues
- Vol. 30  (6) , 416-425
Abortion as a Catastrophic Health Expenditure in the United States